TELENJİEKTAZİ VE RETİKÜLER VARİSLİ HASTALARDA YAŞAM KALİTESİNİN DEĞERLENDİRİLMESİ

Giriş: Venöz yetmezlik her aşamada fiziksel ya da psikolojik etkilerle kişilerin yaşam kalitesini olumsuz etkileyen bir hastalıkdır. Venöz yetmezliğe özgü yaşam kalitesini değerlendirilmek için Venöz Yetmezlikte Epidemiyolojik ve Ekonomik Çalışma-Yaşam Kalitesi/Semptom Ölçeği (VEINES-QoL/Sym scale) geliştirilmiştir. Bu makalede CEAP evre 1 ve 2 hastaların transkutan radyofrekans tedavi sonrası yaşam kalitesi sonuçları araştırılmıştır. Gereç ve Yöntem: Hastanemizde Mayıs 2019-Ocak 2020 tarihleri arasında telenjiektazik varisleri için transkutan radyofrekans tedavisi uygulanan hastalar retrospektif olarak tarandı. Tedavi sonrası yaşam kalitesi VEINESQoL/Sym skalası kullanılarak değerlendirilen hastalar çalışmaya dahil edildi. Kendi isteği ile anketi doldurmayan ya da 18 yaş altındaki hastalar çalışma dışı bırakıldı.Bulgular: Çalışma periyodunda hastanemizde 291 hastaya telenjiektazi nedeniyle transkutan radyofrekans tedavisi uygulandı. Bu hastalardan KEAP evre 1 ve 2 lezyonu ve VEINES-QOL / Sym ölçeğini dolduran 91 hasta çalışmaya dahil edildi. Hastaların yaklaşık 2 / 3'ünde telenjiektaziye ek olarak retiküler varisler vardı. Hastaların yarısından fazlasında semptomlar günün sonunda gelişiyordu. Belirtilerin bir yıl önceki ile karşılaştırılmasında hastaların yaklaşık% 40'ı şikayetlerinin azaldığını belirtti. Sadece % 13'ünde son 4 hafta içinde şiddetli bacak ağrısı gelişmişti. Sonuç: Venöz yetmezlik fiziksel ve psikolojik faktörlerle yaşam kalitesini olumsuz etkiler. KEAP evre 1 ve 2 yapılacak girişimsel tedaviler yaşam kalitesinin iyileştirilmesine katkı sağlayabilir.

EVALUATION OF QUALITY OF LIFE İN THE PATIENTS WITH TELANGIECTASIA AND RETICULAR VEINS

Introduction: Venous insufficiency is a disease that negatively affects the quality of life of people with physical or psychological effects at every stage. To evaluate the quality of life for venous insufficiency, the Epidemiological and Economic Work-Quality of Life / Symptom Scale (VEINES-QoL / Sym scale) in Venous Insufficiency has been developed. In this article, the quality of life results of CEAP stage 1 and 2 patients after transcutaneous radiofrequency treatment were investigated. Material and Methods: Patients, who received transcutaneous radiofrequency treatment for telangiectatic varicose veins in our hospital from May 2019 to January 2020, were retrospectively analyzed. Patients, whose quality of life after treatment was evaluated using the VEINES-QoL / Sym scale, were included in the study. Patients who did not fill out the questionnaire voluntarily or were under the age of 18 years old were excluded from the study. Results: In the study period, 291 patients had been treated for telangiectasia, and 91 patients with CEAP stage 1 and 2 lesions, and answered the VEINES-QOL / Sym scale were included in the study. Almost 2/3 of the patients had reticular varicose veins in addition to telangiectasia. Symptoms were developed at the end of the day in more than half of the patients. In the comparison of the symptoms with one year ago, complaints were reduced in approximately 40% of the patients. In the last 4 weeks, 13% had severe leg pain. Conclusion: Venous insufficiency negatively affects the quality of life with physical and psychological factors. Interventional treatments for CEAP stage 1 and 2 diseases, might improve the quality of life.

PDF

___

1. Coban PT, Dirimese E. Evaluation of quality of life after minimally invasive varicose vein treatment. Turkish J Thorac Cardiovasc Surg 2019; 27(1): 49-56.
2. Kurz X, Lamping DL, Kahn SR, Baccaglini U, Zuccarelli F, Spreafico G et al. Do varicose veins affect quality of life? Results of an international population-based study. J Vasc Surg 2001; 34(4): 641-8.
3. Kutlu A, Yilmaz E, Cecen D, Eser E, Ozbakkaloglu A. The Turkish validity and reliability of the venous insufficiency epidemiological and economic study-quality of life/symptoms scales. Angiology 2011; 62 (4): 329-37.
4. Onida S, Lane TRA, Bootun R, Davies AH. Varicose veins and their management. Surgery 2019; 37(2): 73-80.
5. Beresford T, Smith JJ, Brown L, Greenhalgh RM, Davies AH. A comparison of health-related quality of life of patients with primary and recurrent varicose veins. Phlebology 2003; 18(1): 35-7.
6. Lamping DL, Schroter S, Kurz X, Kahn SR, Abenhaim L. Evaluation of outcomes in chronic venous disorders of the leg: Development of a scientifically rigorous, patient-reported measure of symptoms and quality of life. J Vasc Surg 2003; 37(2): 410-9.
7. Cırak Y, Savcı S, Karahan Z, Demirkilic U. Quality of life following acute deep vein thrombosis: the cultural adaptation, reliability and validity of the VEINES-QOL/Sym scale: a Turkish version study. Turkish J Thorac Cardiovasc Surg 2013; 21(3): 659-68.
8. Launois R. Health-related quality-of-life scales specific for chronic venous disorders of the lower limbs. J Vasc Surg Venous and Lym Dis 2015; 3(2): 219-27.
9. Kahn SR, Lamping DL, Ducruet T, Arsenault L, Miron MJ, Roussin A et al. VEINES-QOL/Sym questionnaire was a reliable and valid disease specific quality of life measure for deep venous thrombosis. J Clin Epi 2006; 59(10): 1049-56.
10. Mallick R, Lal BK, Daugherty C. Relationship between patient-reported symptoms,
11. limitations in daily activities, and psychological impact in varicose veins. J Vasc Surg Venous and Lym Dis 2017; 5(2): 224- 37.
12. Kahn SR, M’lan CE, Lamping DL, Kurz X, Berard A, Abenhaim LA et al. Relationship between clinical classification of chronic venous disease and patient-reported quality of life: Results from an international cohort study. J Vasc Surg 2004; 39(4): 823-8.
13. Migdalski L, Kuzdak K. The use of the VEINES-Qol/Sym questionnaire in patients operated for varicose veins. Polski Przeglad Chirurgiczny 2015; 87(10): 491-8.
14. Lal BK, Mallick R, Wright D. Improvement in patient-reported outcomes of varicose veins following treatment with polidocanol endovenous microfoam. Phlebology 2017; 32(5): 342-54.
15. Ceviker K, Sahinalp S, Cicek E, Demir D, Uysal D, Yazkan R et al. Quality of life in patients with chronic venous disease in Turkey: influence of different treatment modalities at 6-month follow-up. Qual Life Res 2016; 25: 1527-36.